These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3468315)

  • 1. Human serum-dependent survival of GM-CFCs in vitro from patients with chronic granulocytic leukemia.
    Frassoni F; Repetto M; Piaggio G; Podestà M; Marmont AM
    Leuk Res; 1987; 11(1):3-6. PubMed ID: 3468315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium.
    De Bruyn C; Delforge A; Bron D; Ley P; de Hemptinne D; Stryckmans P
    Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive survival/proliferation of normal and Ph1-positive haemopoietic cells.
    Frassoni F; Repetto M; Podestà M; Piaggio G; Raffo MR; Sessarego M; Bacigalupo A; Marmont AM
    Br J Haematol; 1986 May; 63(1):135-41. PubMed ID: 3458499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GM-CFC growth in chronic granulocytic leukaemia is not affected by a soluble inhibitor released by aplastic anaemia T-cells or mitogen-primed normal T-lymphocytes.
    Frassoni F; Podesta M; van Lint MT; Marmont A; Rossi E; Vimercati R; Bacigalupo A
    Br J Haematol; 1982 Apr; 50(4):647-53. PubMed ID: 6978148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sensitivity to hyperthermia of human granulocyte/macrophage progenitor cells (CFU-GM) derived from blood or marrow of normal subjects and patients with chronic granulocytic leukaemia.
    Blackburn MJ; Wheldon TE; Field SB; Goldman JM
    Br J Cancer; 1984 Dec; 50(6):745-51. PubMed ID: 6594154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Culture of ovine bone marrow-derived macrophages and evidence for serum factors distinct from M-CSF contributing to their propagation in vitro.
    Francey T; Jungi TW; Rey O; Peterhans E
    J Leukoc Biol; 1992 Jun; 51(6):525-34. PubMed ID: 1613390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic granulocytic leukemia : early detection of metamorphosis with "in vitro" culture of granulocytic progenitors.
    Coiffier B; Bryon PA; Fiere D; Felman P; Gentillomme O; Vu Van H; Viala JJ; Germain D
    Biomedicine; 1980; 33(4):96-8. PubMed ID: 6932975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of granulocyte-macrophage colony formation in patients with chronic myelomonocytic leukemia.
    Katayama T; Miura Y; Suda T; Kusumoto K; Ozawa K; Motoyashi K; Mizoguchi H; Takaku F
    Stem Cells (1981); 1982; 1(6):345-54. PubMed ID: 6183760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of bone marrow cryopreservation in chronic granulocytic leukemia: relation to excessive granulo-macrophagic progenitor pool.
    Douay L; Lopez M; Gorin NC; Nauman A; Giarratana MC; Laporte JP; Stachowiak J; Salmon C; Duhamel G
    Int J Cell Cloning; 1986 Jul; 4(4):250-62. PubMed ID: 2875118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphologic, immunophenotypic and in vitro growth characteristics of blood and bone marrow associated with stem cell mobilisation in patients with lymphoma.
    Ghielmini M; Marangoni G; Pampallona S; Tamasy P; Cavalli F
    Leuk Lymphoma; 2000 Jul; 38(3-4):351-61. PubMed ID: 10830742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylated insulin-like growth factor II promoted expansion of granulocyte-macrophage colony-forming cells in serum-deprived liquid cultures of human peripheral blood cells.
    Schwartz GN; Hudgins WR; Perdue JF
    Exp Hematol; 1993 Oct; 21(11):1447-54. PubMed ID: 8405224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined effects of Il-3, GM-CSF and G-CSF on the in vitro growth of myelodysplastic myeloid progenitor cells.
    Schipperus MR; Sonneveld P; Lindemans J; Vink N; Vlastuin M; Hagemeijer A; Abels J
    Leuk Res; 1990; 14(11-12):1019-25. PubMed ID: 1704083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic characteristics of circulating CFU-GM in chronic granulocytic leukaemia resemble those of CFU-GM in normal marrow and differ from those in normal blood.
    Robak T; Nolasco I; Hibbin J; Goldman JM
    Leuk Res; 1985; 9(8):1023-9. PubMed ID: 2413317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of acetaldophosphamide, a novel stable aldophosphamide analogue, on normal human and leukemic progenitor cells in vitro: implications for use in bone marrow purging.
    Beran M; Andersson BS; Wang Y; McCredie KB; Farquhar D
    Cancer Res; 1988 Jan; 48(2):339-45. PubMed ID: 3275495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the sensitivity of normal human peripheral blood and bone marrow granulocytic-macrophagic and eosinophilic colony forming cells (CFC) to a source of colony stimulating factor.
    Chikkappa G; Phillips PG; Brinson P
    Exp Hematol; 1982 Nov; 10(10):852-8. PubMed ID: 6983975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell culture studies and oncogene expression in juvenile chronic myelogenous leukemia.
    Gualtieri RJ; Castleberry RP; Gibbons J; Miller DM; Berkow RL; Parmley RT; Banks J
    Exp Hematol; 1988 Aug; 16(7):613-9. PubMed ID: 2968914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential inhibition by cytarabine of CFU-GM from patients with chronic granulocytic leukemia.
    Sokal JE; Leong SS; Gomez GA
    Cancer; 1987 Jan; 59(1):197-202. PubMed ID: 3466662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S; Bhalla K; Arlin Z; Howe CW
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.